Drug Research

Cardiovascular disease remains a leading cause of mortality among women, yet the mechanisms of disease progression often differ significantly from those observed in men. For many years, the pharmaceutical industry relied on generalized markers of heart health, which occasionally...

Autoimmune diseases affect women at a disproportionately high rate, with nearly 80 percent of all patients being female. Despite this staggering statistic, the underlying biological reasons for this disparity are only recently being understood with the necessary scientific depth....

World Pharma Today recently spoke with Dr. Thomas Megerian, a physician who has spent three decades in neurodevelopmental medicine. He serves as Clinical Director of the Thompson Autism and Developmental Center at the Children's Hospital of Orange County and...

Roche-owned Genentech has entered into a major collaboration with Earendil Labs to discover and develop bispecific antibodies targeting oncology, in a deal valued at up to $1.5 billion. Deal Structure and Financial Terms Under the terms of the agreement, Earendil will...

AbbVie and Iambic have entered into a multiyear collaboration focused on AI drug discovery across three major therapeutic areas — immunology, neuroscience, and oncology. The partnership brings together Iambic's molecular superintelligence platform and AbbVie's established drug discovery expertise, with...

High-performance liquid chromatography (HPLC) is key to achieving statistical consistency, which is a cornerstone of pharmaceutical quality control (QC). Column performance is vital to the technique's effectiveness, underscoring the importance of lot-to-lot reproducibility when sourcing HPLC columns for drug...

The UK's National Institute for Health and Care Research (NIHR) has opened the first funding round for its Strategic Infrastructure Partnerships programme, inviting applications for a share of £45 million aimed at accelerating the translation of early-stage medical discoveries...